We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-7.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
-$29.7M
Cap. Flow
+$110M
Cap. Flow %
10.28%
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$35.5M
2
GRAB icon
Grab
GRAB
+$33.3M
3
QCOM icon
Qualcomm
QCOM
+$25.7M
4
AMD icon
Advanced Micro Devices
AMD
+$21.8M
5
SE icon
Sea Limited
SE
+$18.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.29%
2 Technology 26.19%
3 Communication Services 11.91%
4 Healthcare 11.24%
5 Real Estate 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
176
Arcus Biosciences
RCUS
$3.57B
$411K 0.04%
15,720
-2,055
-12% -$54.3K
NBP
177
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$410K 0.04%
102,157
-310,000
-75% -$2.35M
VIR icon
178
Vir Biotechnology
VIR
$1.47B
$410K 0.04%
21,284
+2,345
+12% +$59.6K
ARWR icon
179
Arrowhead Research
ARWR
$12.1B
$408K 0.04%
12,351
-1,996
-14% -$80.6K
IOVA icon
180
Iovance Biotherapeutics
IOVA
$2.23B
$407K 0.04%
42,531
-10,224
-19% -$118K
ABNB icon
181
Airbnb
ABNB
$83.7B
$402K 0.04%
3,831
+181
+5% +$20.1K
APH icon
182
Amphenol
APH
$188B
$402K 0.04%
12,018
-562
-4% -$20.4K
CLDX icon
183
Celldex Therapeutics
CLDX
$2.77B
$401K 0.04%
14,278
+78
+0.5% +$2.39K
RARE icon
184
Ultragenyx Pharmaceutical
RARE
$2.65B
$401K 0.04%
9,673
+894
+10% +$45.9K
BEAM icon
185
Beam Therapeutics
BEAM
$2.58B
$395K 0.04%
8,283
-4,954
-37% -$283K
NTRA icon
186
Natera
NTRA
$37.5B
$394K 0.04%
9,002
-3,801
-30% -$181K
VCYT icon
187
Veracyte
VCYT
$4.52B
$394K 0.04%
23,762
+946
+4% +$21.3K
MRTX
188
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$393K 0.04%
5,620
-1,793
-24% -$133K
EA icon
189
Electronic Arts
EA
$52.4B
$389K 0.04%
3,363
+132
+4% +$16.7K
RXDX
190
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$385K 0.04%
+6,532
New +$299K
ROP icon
191
Roper Technologies
ROP
$36.3B
$383K 0.04%
1,066
-49
-4% -$19.9K
EXAS
192
DELISTED
Exact Sciences
EXAS
$381K 0.04%
11,718
+1,098
+10% +$45.3K
TWST icon
193
Twist Bioscience
TWST
$5.62B
$381K 0.04%
10,817
-5,534
-34% -$235K
FATE icon
194
Fate Therapeutics
FATE
$281M
$380K 0.04%
16,952
-5,151
-23% -$149K
ANSS
195
DELISTED
Ansys
ANSS
$378K 0.04%
1,703
-41
-2% -$10.5K
ENPH icon
196
Enphase Energy
ENPH
$4.84B
$377K 0.04%
1,359
-63
-4% -$17K
MSI icon
197
Motorola Solutions
MSI
$69.4B
$377K 0.04%
1,682
-78
-4% -$18.4K
CVS icon
198
CVS Health
CVS
$137B
$375K 0.03%
3,934
+270
+7% +$26.7K
WMT icon
199
Walmart Inc
WMT
$871B
$374K 0.03%
8,658
+294
+4% +$12.9K
EDIT icon
200
Editas Medicine
EDIT
$399M
$368K 0.03%
30,092
-9,249
-24% -$144K

Similar funds

E Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management held 349 positions worth $1.07B, down 2.7% from $1.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $110M of net new capital in Q3 2022, opening 26 new positions and adding to 163 existing holdings. Its largest new stake was TSMC: 430,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Mercado Libre, an estimated $26.6M trimmed.

  • E Fund Management's largest Q3 2022 buy was TSMC: 430,000 shares worth $29.5M.
  • E Fund Management added most to Grab in Q3 2022, an estimated $33.3M increase.
  • E Fund Management's biggest Q3 2022 reduction was Mercado Libre, cutting an estimated $26.6M.
  • E Fund Management fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management's ten largest holdings make up 56% of its $1.07B portfolio in Q3 2022.
  • E Fund Management opened 26 new positions and closed 15 in Q3 2022.
  • E Fund Management's portfolio value fell 2.7% quarter-over-quarter to $1.07B.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.